Trials / Recruiting
RecruitingNCT05667519
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 324 (estimated)
- Sponsor
- LMU Klinikum · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years.
Detailed description
Lead-induced tricuspid regurgitation is a frequent complication after pacemaker- and ICD-implantation that is associated with increased mortality and hospitalizations for heart failure. Transesophageal echocardiography has shown to be a safe and feasible way to guide right ventricular lead placement and was associated with less worsening of tricuspid regurgitation than standard lead implantation in a small study with a retrospective control group. This is the first randomized controlled trial comparing transesophageal echocardiography + fluoroscopy guided lead implantation vs. standard lead implantation guided by fluoroscopy only. Patients are randomized 1:1 in the two groups and followed up for up to 3 years. Echocardiographic grading of the primary endpoint will be performed by a blinded echocardiographer according to current guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Additional guidance of lead implantation by transesophageal echocardiography | Transesophageal echocardiography guidance of lead implantation targeting a stable lead position in a tricuspid valve commissure (preferentially postero-septal) and an apical ventricular lead position |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
- First posted
- 2022-12-28
- Last updated
- 2022-12-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05667519. Inclusion in this directory is not an endorsement.